A new device to improve hip and leg fracture surgery
Official title: Fluoroscopic drill attachment for orthopedic trauma surgery
Funded at Eclipse Orthopaedics, LLC · NIH-10932389 · Data updated 2026-11-12
This study is testing a new tool designed to help orthopedic surgeons do hip and leg fracture surgeries more accurately and quickly, which could lead to better results and less radiation exposure for everyone involved.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Eclipse Orthopaedics, LLC NIH-funded |
| Lab location | 1 site (Warsaw, United States) |
| Project start | September 22, 2023 |
| Project end | July 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $1,104,076 |
| NIH project number | 5R44AR082780-02 |
| Project ID | NIH-10932389 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals suffering from hip or leg fractures requiring surgical intervention.
✕Less likely to help
Patients with fractures that do not require surgical fixation or those who are not candidates for intramedullary nailing may not benefit from this research.
What this research studies
This research focuses on developing a novel device called the Radiographic Targeting Attachment™ (RTA) to assist orthopedic surgeons in performing distal locking during intramedullary nail procedures for hip and leg fractures. The RTA aims to enhance precision and reduce the time required for surgery, thereby minimizing radiation exposure for both surgeons and patients. By allowing surgeons to perform targeting and drilling more effectively, this device seeks to improve overall surgical outcomes and reduce complications associated with traditional methods.
Why it matters
Potential benefit: If successful, this research could lead to safer and more efficient surgeries for patients with hip and leg fractures.
How similar studies have gone: Other research has shown promise in improving surgical techniques and reducing radiation exposure, indicating that this approach could be beneficial.
Where this research is happening
-
Eclipse Orthopaedics, LLC
Warsaw, United States Active
Researchers
- Principal investigator: Rich, David Boyd — Eclipse Orthopaedics, LLC
- Study coordinator: Rich, David Boyd
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.